ID: ALA3342211
Max Phase: Preclinical
Molecular Formula: C46H48N2O19S
Molecular Weight: 964.95
Molecule Type: Small molecule
Associated Items:
ID: ALA3342211
Max Phase: Preclinical
Molecular Formula: C46H48N2O19S
Molecular Weight: 964.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@]12OC[C@]34[C@H]([C@@H](O)[C@@H]1O)[C@@]1(C)CC(=O)C(OC(=O)c5ccccc5C(=O)OCCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)=C(C)[C@@H]1C[C@H]3OC(=O)[C@H](OC(=O)C=C(C)C)[C@@H]24
Standard InChI: InChI=1S/C46H48N2O19S/c1-23(2)19-31(50)65-34-36-45-22-63-46(36,43(56)60-5)37(52)32(51)35(45)44(4)21-29(49)33(24(3)28(44)20-30(45)64-42(34)55)66-41(54)27-16-10-9-15-26(27)40(53)62-18-12-11-17-61-38-39(48(57)67-47-38)68(58,59)25-13-7-6-8-14-25/h6-10,13-16,19,28,30,32,34-37,51-52H,11-12,17-18,20-22H2,1-5H3/t28-,30+,32+,34+,35+,36+,37-,44-,45+,46+/m0/s1
Standard InChI Key: IASBNEUEFIKZJY-DBZNAARSSA-N
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 964.95 | Molecular Weight (Monoisotopic): 964.2572 | AlogP: 2.29 | #Rotatable Bonds: 14 |
Polar Surface Area: 294.60 | Molecular Species: NEUTRAL | HBA: 20 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 21 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.75 | CX Basic pKa: | CX LogP: 2.67 | CX LogD: 2.67 |
Aromatic Rings: 3 | Heavy Atoms: 68 | QED Weighted: 0.08 | Np Likeness Score: 1.60 |
1. Tang W, Xie J, Xu S, Lv H, Lin M, Yuan S, Bai J, Hou Q, Yu S.. (2014) Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies., 57 (18): [PMID:25179783] [10.1021/jm5007534] |
Source(1):